During gestation, in laboratory animals and women, maternal spinal opioid analgesic systems are activated. This analgesia is mediated by a spinal cord dynorphin/kappa and enkephalin/delta (delta-1 and delta-2) opioid system. One underlying objective of the proposed research is to elucidate the relationship between the multiple spinal opioid analgesic systems that comprise the analgesia of pregnancy. This proposal is also designed to determine the biochemical changes that underlie the adaptation of spinal dynorphin neurons to the increased demands of pregnancy. The specific objects are to (1) Determine if the analgesia of pregnancy is comprised of the sum of separate, independent spinal cord analgesic systems or if it requires their concomitant activation. (2) Determine if gestational-related antinociception involves the modulation of spinal cord opiate receptors.
This aim will utilize opiate receptor immunohistochemistry and autoradiography. (3) Determine the spectrum of dynorphin intermediates that are present in the spinal cord of pregnant and non-pregnant rats and identify those whose concentration is (are) modulated (decreased) during late gestation. (4) Determine whether or not the precursor processing endoproteases PC1 and PC2 are modulated in maternal spinal cord during pregnancy. This study will involve a quantitative comparison of PC1 and PC2 mRNA and PC1 and PC2 enzyme protein in spinal cord obtained from pregnant and non-pregnant rats. (5) Determine the effect of simulating the pregnancy blood concentration profile of 17-beta-estradiol and progesterone on spinal cord dynorphin precursor content and the hormone precursor processing enzymes PC1 and PC2. This research could have direct relevance to the clinical management of the pain of pregnancy and childbirth. Elucidation of the components of the intrinsic pain-attenuating opioid system(s) that are activated during gestation could provide a basis for their manipulation for medicinal purposes. Identification of changes in a particular receptor type or subtype could provide a rationale for the development of more selective drugs for use in labor and delivery. Such information should also heighten awareness of the influence of gender on intrinsic pain attenuating mechanisms. Since stress and exogenous opioids can impact on immune function, a better understanding of how endorphin systems are activated during gestation could ultimately be relevant to treating aids in pregnant women. Finally, it should be noted that during pregnancy, there occurs a sustained activation of intrinsic opioid analgesic activity without the appearance of dependence formation. Thus, the means by which and the combinations in which spinal opioid systems are activated in response to the 'stress' of pregnancy and the underlying adaptive biochemical processes utilized by them under this condition could be relevant to understanding opioid addictive processes in general.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002893-12
Application #
2733487
Study Section
Special Emphasis Panel (SRCD (22))
Project Start
1980-05-01
Project End
2000-06-30
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
12
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Suny Downstate Medical Center
Department
Biochemistry
Type
Schools of Medicine
DUNS #
068552207
City
Brooklyn
State
NY
Country
United States
Zip Code
11203
Liu, Nai-Jiang; vonGizycki, Hans; Gintzler, Alan R (2006) Phospholipase Cbeta1 modulates pain sensitivity, opioid antinociception and opioid tolerance formation. Brain Res 1069:47-53
Dow-Edwards, D L; Milhorat, T H; Freed, L A et al. (1989) Regional brain glucose utilization during and following chronic naltrexone administration: preliminary observations in rat brain. Life Sci 44:571-7
Xu, H; Smolens, I; Gintzler, A R (1989) Opioids can enhance and inhibit the electrically evoked release of methionine-enkephalin. Brain Res 504:36-42
Sharma, T R; Chan, W C; Gintzler, A R (1988) Effect of chronic naltrexone administration and its withdrawal on the regional activity of neurons that contain norepinephrine, dopamine and serotonin. Brain Res 442:379-86
Sander, H W; Portoghese, P S; Gintzler, A R (1988) Spinal kappa-opiate receptor involvement in the analgesia of pregnancy: effects of intrathecal nor-binaltorphimine, a kappa-selective antagonist. Brain Res 474:343-7
Sander, H W; Gintzler, A R (1987) Spinal cord mediation of the opioid analgesia of pregnancy. Brain Res 408:389-93
Glass, J; Chan, W C; Gintzler, A R (1986) Direct analysis of the release of methionine-enkephalin from guinea pig myenteric plexus: modulation by endogenous opioids and exogenous morphine. J Pharmacol Exp Ther 239:742-7
Glass, J; Clouet, D; Gintzler, A R (1986) Short-term nerve stimulation increases enkephalin production and content in the guinea pig myenteric plexus. Brain Res 372:180-4
Baron, S A; Testa, F M; Gintzler, A R (1985) Simultaneous quantitation of norepinephrine, dopamine and serotonin in brain during and following chronic naltrexone administration. Brain Res 340:192-8